Zensyon Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth 226.93%
- Profit Growth -187.99%
- Ebitda -29.34%
- Net Worth -952.43%
- Total Assets 3097.15%
About Zensyon Lifesciences
Zensyon Lifesciences Private Limited (ZLPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 05 April 2017 (Seven years and ten months 16 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Patkar and Aishwarya Patkar serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2017PTC293422
- Company No.
293422
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Apr 2017
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Zensyon Lifesciences Private Limited offer?
Zensyon Lifesciences Private Limited offers a wide range of products and services, including Fresh, Dried & Preserved Fruits, Fruit Pulp, Mangoes.
Who are the key members and board of directors at Zensyon Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Patkar  | Additional Director | 29-Nov-2017 | Current |
| Aishwarya Patkar | Director | 05-Apr-2017 | Current |
Financial Performance of Zensyon Lifesciences.
Zensyon Lifesciences Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 226.93% increase. The company also saw a substantial fall in profitability, with a 187.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 952.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zensyon Lifesciences?
In 2019, Zensyon Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zensyon Lifesciences?
Unlock and access historical data on people associated with Zensyon Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zensyon Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zensyon Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
